Aparna Hima Jonnal, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Us 1 Hwy Ste 100, Youngsville, NC 27596 Phone: 919-562-2340 |
News Archive
Health authorities worldwide are coping with rising costs and disability resulting from fragility fractures in the older population.
Can a drug that has been used to treat malaria for years possibly be used to treat breast cancer before it becomes invasive? That's what researchers at George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) and Inova Breast Care Institute (IBCI) are trying to prove.
EndoGastric Solutions (EGS), the leader in endoluminal reconstructive treatment for gastroesophageal reflux disease (GERD), announced today that enrollment for the RESPECT study (Randomized EsophyX vs. Sham/Placebo Controlled Trial) is complete and has surpassed the company's original target of 120 patients.
The Department of Health and Human Services (HHS) has awarded Albert Einstein College of Medicine of Yeshiva University a three-year, $2.1 million grant to expand and enrich its Hispanic Center of Excellence (HCOE).
40 percent of people in the EU suffer from non-alcoholic steatohepatitis (fatty liver disease), a disease which is becoming increasingly more frequent as a result of diabetes and excess weight in an affluent society. Currently, it is not possible to forecast the further course of the disease - right up to cirrhosis and cancer of the liver. Furthermore, an increased risk of heart attack and kidney damage exists. In future, this should become possible using a Risk Score with different biomarkers.
› Verified 4 days ago